<DOC>
	<DOC>NCT02858271</DOC>
	<brief_summary>Open-label, single-dose, Phase 1 study to assess the absorption, metabolism, excretion and pharmacokinetics of [14C]-AKB-9778 in healthy male volunteers</brief_summary>
	<brief_title>Study to Assess the Absorption, Metabolism, Excretion and Pharmacokinetics of [14C]-AKB-9778</brief_title>
	<detailed_description />
	<criteria>BMI 18 33 kg/m2 Significant cardiovascular, pulmonary, or renal disease</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>